Otto, Karl
Radformation,
United States
2025 Rank: 323,065
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,937 out of 122,662 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 323,065 | 372,685 |
| Total Cites | 124 | 124 |
| H-index | 5 | 5 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 62 | 62 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 64 | 64 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 101 | 101 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 113 | 113 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
0.00%
|
|
Otto, Karl
Limbus AI Inc,
Canada
2024 Rank: 206,003
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,215 out of 116,246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 206,003 | 235,031 |
| Total Cites | 149 | 150 |
| H-index | 6 | 6 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 78 | 78 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 78 | 78 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 121 | 121 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 132 | 132 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
0.67%
|
|
Otto, Karl
Limbus AI Inc,
Canada
2023 Rank: 168,431
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,011 out of 109,758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 168,431 | 197,052 |
| Total Cites | 183 | 183 |
| H-index | 5 | 5 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 83 | 83 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 86 | 86 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 157 | 157 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 154 | 154 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.19 |
| Self-Citation Percentage |
0.00%
|
|
Otto, Karl
Limbus AI Inc,
Canada
2022 Rank: 146,556
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 913 out of 105,572 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 146,556 | 172,693 |
| Total Cites | 190 | 191 |
| H-index | 5 | 5 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 102 | 102 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 103 | 103 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 174 | 174 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 159 | 160 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.19 |
| Self-Citation Percentage |
0.52%
|
|
Otto, Karl
Limbus AI Inc,
Canada
2021 Rank: 152,043
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 957 out of 101,860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152,043 | 174,549 |
| Total Cites | 268 | 269 |
| H-index | 6 | 6 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 137 | 137 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 142 | 142 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 241 | 241 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 219 | 220 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.22 |
| Self-Citation Percentage |
0.37%
|
|
Otto, Karl
The University of British Columbia,
Canada
2020 Rank: 85,594
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 481 out of 84,246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85,594 | 98,636 |
| Total Cites | 240 | 242 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 120 | 121 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 123 | 124 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 211 | 212 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 193 | 195 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.24 |
| Self-Citation Percentage |
0.83%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.